GetTopicDetailResponse(id=c2ae42630ba, topicName=復(fù)宏漢霖, introduction=復(fù)宏漢霖, content=null, image=null, comments=5, allHits=1370, url=https://h5.medsci.cn/topic?id=42630, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=18027, tagList=[TagDto(tagId=18027, tagName=復(fù)宏漢霖)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1418454, encodeId=47f0141845405, content=<a href='/topic/show?id=c2ae42630ba' target=_blank style='color:#2F92EE;'>#復(fù)宏漢霖#</a>, objectTitle=復(fù)宏漢霖2021年上半年?duì)I收6.33億元 同比增長(zhǎng)474%, objectType=article, longId=215993, objectId=5bc52159936f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bc52159936f, replyNumber=0, likeNumber=76, createdTime=2021-08-21, rootId=0, userName=FukaiBao, userId=2dd53361593, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bc52159936f, moduleTitle=復(fù)宏漢霖2021年上半年?duì)I收6.33億元 同比增長(zhǎng)474%, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5bc52159936f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418453, encodeId=655214184536e, content=<a href='/topic/show?id=c2ae42630ba' target=_blank style='color:#2F92EE;'>#復(fù)宏漢霖#</a>, objectTitle=復(fù)宏漢霖獲潤(rùn)新生物BRAF抑制劑權(quán)益，合作金額**超10億元, objectType=article, longId=209533, objectId=155e209533de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=155e209533de, replyNumber=0, likeNumber=91, createdTime=2021-04-05, rootId=0, userName=FukaiBao, userId=2dd53361593, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=155e209533de, moduleTitle=復(fù)宏漢霖獲潤(rùn)新生物BRAF抑制劑權(quán)益，合作金額**超10億元, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=155e209533de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418452, encodeId=c0691418452c2, content=<a href='/topic/show?id=c2ae42630ba' target=_blank style='color:#2F92EE;'>#復(fù)宏漢霖#</a>, objectTitle=復(fù)宏漢霖貝伐珠單抗上市注冊(cè)申請(qǐng)獲NMPA受理, objectType=article, longId=200558, objectId=090a200558bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=090a200558bc, replyNumber=0, likeNumber=103, createdTime=2020-09-12, rootId=0, userName=FukaiBao, userId=2dd53361593, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=090a200558bc, moduleTitle=復(fù)宏漢霖貝伐珠單抗上市注冊(cè)申請(qǐng)獲NMPA受理, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=090a200558bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418451, encodeId=61aa14184510a, content=<a href='/topic/show?id=c2ae42630ba' target=_blank style='color:#2F92EE;'>#復(fù)宏漢霖#</a>, objectTitle=復(fù)宏漢霖曲妥珠單抗生物類(lèi)似物獲歐盟批準(zhǔn)上市, objectType=article, longId=198341, objectId=5c4c198341c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c4c198341c7, replyNumber=0, likeNumber=86, createdTime=2020-07-31, rootId=0, userName=醫(yī)者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c4c198341c7, moduleTitle=復(fù)宏漢霖曲妥珠單抗生物類(lèi)似物獲歐盟批準(zhǔn)上市, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5c4c198341c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418450, encodeId=45411418450b9, content=<a href='/topic/show?id=c2ae42630ba' target=_blank style='color:#2F92EE;'>#復(fù)宏漢霖#</a>, objectTitle=復(fù)宏漢霖獲得單克隆抗體藥物臨床批件, objectType=article, longId=32937, objectId=8e9b3293eeb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e9b3293eeb, replyNumber=0, likeNumber=104, createdTime=2014-04-06, rootId=0, userName=FukaiBao, userId=2dd53361593, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e9b3293eeb, moduleTitle=復(fù)宏漢霖獲得單克隆抗體藥物臨床批件, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8e9b3293eeb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
